By DeMario Moore, Julian Braz, PhD
This course examines the diagnostic and prognostic applications of BNP and NT-proBNP in patients with suspected or established heart failure. It reviews evidence linking natriuretic peptide concentrations with adverse cardiovascular outcomes, mortality, and rehospitalization risk, while emphasizing appropriate interpretation within the context of comorbidities, clinical presentation, and applicable guidelines.
LEARNING OBJECTIVES
Upon completion of this article, the reader will be able to:
- Identify the established diagnostic roles of BNP and NT-proBNP in the evaluation of patients with suspected heart failure.
- Differentiate between the diagnostic and prognostic applications of natriuretic peptide testing.
- Interpret key evidence-based findings regarding the prognostic significance of BNP and NT-proBNP concentrations, including their association with adverse cardiovascular outcomes and rehospitalization risk.
About the Presenters
DeMario Moore is a Senior Manager of Global Product Marketing at Beckman Coulter Diagnostics, where he focuses on the DxI 9000 Immunoassay Analyzer and cardiovascular
solutions. His experience spans product strategy, commercialization, and healthcare
innovation, with a strong focus on connecting clinical needs, market insights, and customer
value. He is passionate about advancing diagnostic solutions that help laboratories and
clinicians make more informed decisions and ultimately improve patient care.
Julian Braz, PhD is Senior Director, Medical & Scientific Affairs – Cardiometabolic at Beckman Coulter Diagnostics.
He holds a PhD in Cardiovascular Pharmacology and brings 20
years of experience across the pharmaceutical
and in vitro diagnostics industries.
Course Includes
- 1 Lesson
- 1 Test
- Course Certificate
Medical Laboratory Observer (MLO) is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. ® Program.
Level of Instruction: Intermediate
Passing scores of 70 percent or higher are eligible for 1 contact hour of P.A.C.E. credit. This test is no longer valid for CEs after October 2027.
